Tag: Nirmatrelvir/ritonavir

A large observational study in Israeli and US health records found that exposure to the antimalarial drugs atovaquone-proguanil and mefloquine, ...

A 15-center Italian retrospective cohort found 30-day hospitalization or death in 0.9% of 3,916 high-risk outpatients treated early with nirmatrelvir/ritonavir, ...

In a landmark study published in Nature Communications in 2025, researchers Guo, Wei, Lin, and colleagues have delivered compelling evidence ...